Stoke Therapeutics, Inc. (STOK)

35.78 +0.17 (+0.48%) USD  |  NASDAQ  |  Apr 22, 13:23
More

Stoke Therapeutics Sell Recommendations

Sell Recommendations Chart

View Sell Recommendations for STOK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sell Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sell Recommendations Range, Past 5 Years

View Sell Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sell Recommendations Benchmarks

View Sell Recommendations Benchmarks
Start Trial
Biogen, Inc. Upgrade
Krystal Biotech, Inc. Upgrade
Scholar Rock Holding Corp. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Zymeworks, Inc. Upgrade